The ACME Laboratories Ltd. (DSE: ACMELAB)
Health Care · Pharmaceuticals · BD
Tk77.80
-0.51% today · +1.2% 1Y
The ACME Laboratories Ltd. (DSE: ACMELAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $133.67M.
Over the last twelve months the share price has gained 1.2%, trading between 68.60 and 88.70.
Tweenvest scores The ACME Laboratories Ltd. across four factors: quality 67/100, value 75/100, growth 49/100, dividend 35/100. Its strongest factor is value.
ACMELAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $133.67M
- Revenue (TTM)
- $326.55M
- P/E
- 6.18
- EPS
- 12.60
- Dividend yield
- 4.50%
- Beta (5Y)
- 0.12
- 52-week high
- Tk88.70
- 52-week low
- Tk68.60
- Avg volume (3M)
- —
- Shares outstanding
- 211.60M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PT Kimia Farma TbkIDX: KAEF | $135.63M | Rp436.00 | +5.83% |
| Organigram Global Inc.TSX: OGI | $135.39M | CA$1.37 | +0.74% |
| Vivozon Pharmaceutical Co., Ltd.KOSDAQ: A082800 | $134.71M | ₩3,010.00 | +1.69% |
| Sinew Pharma Inc.TPEX: 6634 | $133.99M | NT$60.10 | -9.21% |
| Samil Pharmaceutical Co.,LtdKOSE: A000520 | $132.73M | ₩8,350.00 | -2.91% |
| Bharat Parenterals LimitedBSE: 541096 | $132.61M | Rs1,862.25 | +8.43% |
| Chong Kun Dang Holdings Corp.KOSE: A001630 | $131.91M | ₩37,250.00 | -0.27% |
| Flerie AB (publ)OM: FLERIE | $131.79M | Skr15.20 | -2.56% |
Figures last refreshed Oct 11, 2026.